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PtdIns4P is the major precursor for the synthesis of the
multifunctional plasma membrane lipid, PtdIns(4,5)P2.Y e t
PtdIns4P also functions as a regulatory lipid in its own right,
particularly at the Golgi apparatus. In the present study we
deﬁne speciﬁc conditions that enable preservation of several
organellar membranes for the immunocytochemical detection of
PtdIns4P. We report distinct pools of this lipid in both Golgi
and plasma membranes, which are synthesized by different
PI4K (phosphatidylinositol 4-kinase) activities, and also the
presence of PtdIns4P in cytoplasmic vesicles, which are not
readily identiﬁable as PI4K containing trafﬁcking intermediates.
In addition, we present evidence that the majority of PtdIns4P
residesintheplasmamembrane,whereitismetabolicallydistinct
from the steady-state plasma membrane pool of PtdIns(4,5)P2.
Key words: Golgi, immunoﬂuorescence, phosphoinositides,
plasma membrane, PtdIns(4,5)P2,P t d I n s 4 P.
INTRODUCTION
PtdIns4P is the most functionally diverse of the inositol lipids.
Firstly, synthesis of the versatile signalling lipid PtdIns(4,5)P2
proceeds primarily via 5-phosphorylation of PtdIns4P [1].
PtdIns(4,5)P2 is in turn the precursor for generation of the
signalling lipid PtdIns(3,4,5)P3 and PtdIns(3,4)P2 [2]. Therefore
PtdIns4P synthesis can be considered to be a crucial step in
the regulation of the numerous cellular processes under the
control of these lipids [2–4]. Secondly, accumulating evidence
implicates PtdIns4P as a regulatory molecule in its own right,
via its interaction with a unique repertoire of binding proteins
(reviewedin[5]).SynthesisofaGolgipoolofPtdIns4Pisrequired
for protein secretion in budding yeast [6,7] and PtdIns4P’s
interaction with a variety of adaptor proteins is required for
vesicular trafﬁc from the mammalian Golgi apparatus [8–10],
where it is also required for non-vesicular transport and synthesis
of sphingolipids [11,12]. Beyond the Golgi apparatus, PtdIns4P
has been implicated in the control of vesicular trafﬁc in the
endocytic pathway [13–15] and to function in regulated secretory
organelles [16–18].
PtdIns4P synthesis is catalysed by activity of PI4K
(phosphatidylinositol 4-kinase). There are two evolutionarily
diverse PI4Ks, the wortmannin-insensitive type II, and the
wortmannin-sensitive type III. α and β isoforms of each are
found in mammals (reviewed in [1]). Although much is known
about the subcellular distribution of these enzymes, this does not
necessarily inform as to the distribution of the active population,
or localization of the lipid product. For example PI4K IIIα
is found predominantly at the ER (endoplasmic reticulum)
[19], yet is responsible for synthesis of a plasma membrane
pool of PtdIns(4,5)P2 hydrolysed during PLC (phospholipase
C) signalling [20]. Therefore, obtaining information on the
subcellular distribution of PtdIns4P will be particularly useful
for understanding the diverse functions of this molecule.
Imaging of living cells expressing ﬂuorescent proteins fused
to inositol lipid-binding domains has revolutionized the study
of these lipids [21]. However, studies using PtdIns4P-binding
ﬂuorescent proteins have carried a number of caveats. Firstly, a
family of PtdIns4P-binding PH (pleckstrin homology) domains,
including those from FAPP1 (phosphatidylinositol-4-phosphate
adaptor protein 1, also known as PLEKHA3) and OSBP
(oxysterol-binding protein), were found to detect the lipid in
Golgimembranes,butonlywhenitwasco-incidentwiththesmall
GTPase Arf1 (ADP-ribosylation factor 1) [10,22]. Secondly, the
Osh2p (a yeast homologue of OSBP) PH domain was found to
bind PtdIns4P and PtdIns(4,5)P2 in vitro [23], but to bind plasma
membrane PtdIns4P exclusively when expressed in cells [20,23].
To try and clarify the subcellular distribution of PtdIns4P,w e
have been developing techniques for the immunocytochemical
detection of this lipid, using a commercially available antibody.
In the present study, we describe conditions for the cytochemical
preservation of a number of organellar membranes and the
detection of PtdIns4P in a subset of these (the plasma membrane
andGolgi).Furthermore,wehaveusedthesetechniquestoanalyse
the biosynthesis and biological features of different cellular pools
of PtdIns4P and PtdIns(4,5)P2.
EXPERIMENTAL
Materials and antibodies
Monoclonal anti-PtdIns(4,5)P2 antibody (clone 2C11) and anti-
PtdIns4P antibody (both IgM) are from Echelon Biosciences,
Abbreviations used: Arf1, ADP-ribosylation factor 1; DAPI, 4 ,6-diamidino-2-phenylindole; DiD, 1,1 -dioctadecyl-3,3,3 ,3 -tetramethylindodicarbo-
cyanineperchlorate; DiOC6,3 , 3  -dihexyloxacarbocyanine iodide; DMEM, Dulbecco’s modiﬁed Eagle’s medium; DTT, dithiothreitol; EGF, epidermal growth
factor; ER, endoplasmic reticulum; ERGIC, ER-Golgi intermediate compartment; FA, formaldehyde; FAPP1, phosphatidylinositol-4-phosphate adaptor
protein 1; FYVE-Hrs, hepatocyte growth factor-regulated tyrosine kinase substrate; GA, glutaraldehyde; GFP, green ﬂuorescent protein; GM130, cis-Golgi
matrix protein of 130 kDa; GST, glutathione transferase; M6PR, mannose-6-phosphate receptor; NBD-C6-ceramide, N-(ε-7-nitrobenz-2-oxa-1,3-diazol-4-yl-
aminocaproyl)-D-erythro-sphingosine; NGS, normal goat serum; OSBP, oxysterol-binding protein; PAO, phenylarsine oxide; PH, pleckstrin homology; PI3K,
phosphoinositide 3-kinase; PI4K, phosphoinositide 4-kinase; PLC, phospholipase C; POPC, 1-palmitoyl 2-oleoyl phosphatidylcholine; TBS, tris-buffered
saline; WGA, wheat germ agglutinin.
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and were used at 2.5 and 8 μg/ml respectively. We also used
a monoclonal anti-γ-adaptin antibody [clone 100/3; Sigma–
Aldrich, an IgG2b (a gift from M. Robinson, Cambridge Institute
for Medical Research, Cambridge, U.K.)] at 1:500, anti-GM130
(cis-Golgi matrix protein of 130 kDa) antibody and anti-p115
antibody (BD Transduction Laboratories, both IgG1) at 1:400
and anti-δ-adaptin (a gift from A. Peden, Cambridge Institute for
Medical Research, Cambridge, U.K.; [24]) at 1:5000. Polyclonal
rabbit anti-giantin antibody and anti-M6PR (mannose-6-
phosphate receptor) antibody (both from Abcam) were used at
a 1:500 and 1:125 dilutions from the supplied concentration
respectively. Antibodies were stored at −20◦Ci n5 0% glycerol.
Anti-GST (glutathione transferase) antibody (Chemicon) was
stored at 4◦C and used at 5 μg/ml. Highly cross-absorbed Alexa
Fluor® 488, Alexa Fluor® 555 and Alexa Fluor® 647 goat
anti-mouse antibody or anti-rabbit IgGs (H+L) antibodies, as
well as goat anti-mouse IgM, IgG1 and IgG2b antibodies were
from Invitrogen. These were stored at −20◦Ci n5 0% glycerol
and used at a concentration of 5 μg/ml. Biotinylated EGF
(epidermal growth factor) pre-conjugated with streptavidin Alexa
Fluor® 488 (Invitrogen) was dissolved in PBS with 1% (w/v)
BSA to 200 μg/ml, and stored in single-use aliquots at −20◦C.
16% (w/v) methanol-free FA (formaldehyde) and 25% (v/v)
electron microscopy grade GA (glutaraldehyde) stock solutions
were purchased from TAAB Laboratories. FA was diluted to 8%
( v / v )i nP B Sa n ds t o r e da t−20◦C. Alcohol soluble, high-purity
digitonin (Calbiochem) was prepared as a 20 mM stock solution
in DMSO and stored in single-use aliquots at −20◦C. Saponin
(from Quillaja bark; Sigma–Aldrich) was dissolved to 5% (w/v)
in buffer A (20 mM Pipes, pH 6.8, 137 mM NaCl, 2.7 mM KCl)
andstoredinsingleusealiquotsat−20◦C.Wortmanninwasfrom
Calbiochem and all other reagents were from Sigma–Aldrich.
POPC (1-palmitoyl 2-oleoyl phosphatidylcholine; Avanti Polar
Lipids) liposomes containing 5% (mol/mol) of the indicated
dipalmitoyl inositol lipids (Echelon Biosciences) were prepared
from a dried ﬁlm of lipid (2 h under high vacuum) by hydration
andsonicationinbufferAtoaﬁnalconcentrationof140 μMtotal
[lipid]. Liposomes were stored at room temperature and used on
the day of preparation.
Plasmids encoding GFP (green ﬂuorescent protein)–2×
FYVE-Hrs (hepatocyte growth factor-regulated tyrosine kinase
substrate) for mammalian expression and GST–2xFYVE-Hrs
for bacterial expression [25], were a gift from H. Stenmark
(The Norwegian Radium Hospital, Oslo, Norway). Bacterial
expression vectors encoding GST–tagged PH-FAPP1 (human)
and PH-PLCδ1 (rat) were gifts from O. Gozani (Stanford
University, Stanford, Ca, U.S.A.) and M. Katan (The Institute
of Cancer Research, London, U.K.) respectively. PH-FAPP1–
GFP [26] was a gift from T. Balla (National Institute of Child
Health and Human Development, Bethesda, MD, U.S.A.). GFP–
Pharbinwas usedasdescribed previouslyin[27], andtheputative
catalytic residue aspartate-559 was mutated to alanine by site-
directed mutagenesis. All constructs were checked by dideoxy
sequencing.
Proteins
Bacterial expression vectors encoding GST-tagged proteins were
transformed into BL21 (DE3) E. coli cells (Promega) by heat
shock,andsinglecoloniesweregrownin500 mlof2× YTmedia
(1.6% (w/v) tryptone, 1.0% (w/v) yeast extract, 0.5% NaCl,
50 μg/ml ampicillin) until an attenuance at 600 nm (D600)o f0 . 6 –
1.5 was reached, at which time protein expression was induced
by addition of IPTG (isopropyl β-D-thiogalactoside; Sigma–
Aldrich) to a ﬁnal concentration of 1 mM. After 3 h at 37◦C
with vigorous shaking, cells were harvested by centrifugation
at 3000 g, washed twice in ice-cold TBS (Tris-buffered saline;
10 mM Tris/HCl, pH 8.0, 150 mM NaCl) and re-suspended in
20 ml TBS with 1 mM EDTA, 0.5 mM PMSF, 4 μg/ml pepstatin
A, 1 mM benzamidine HCl and 0.1% 2-mercaptoethanol. The
suspension was lysed by incubation with 2 mg lysozyme for
30 min at 4◦C with gentle agitation, followed by sonication and
further agitation for 30 min at 4◦C with Triton X-100 added to
1% (w/v). Insoluble material was removed by centrifugation at
18000 g for 20 min at 4◦C, and the cleared lysate added to 2.5 ml
packed GSH–Sepharose beads; GST-tagged proteins were left to
bind overnight at 4◦C with gentle agitation. After two washes
with cold TBS, proteins were eluted twice by addition of 50 mM
GSH in TBS (pH re-adjusted to 8.0). The eluates were pooled and
concentrated by dialysis with a 3.5 kDa molecular mass cut-off
dialysis membrane against 8 kDa poly(ethylene glycol) in buffer
A,followedbyfurtherextensivedialysisinbufferA.Proteinswere
quantiﬁed by the Bradford reagent and by Coomassie Brilliant
Blue staining of polyacrylamide gels with densitometric analysis
of BSA standards; comparison of the two results estimated the
proteinsas95%pure.Proteinswereﬂashfrozeninliquidnitrogen
in single use aliquots and stored at −80◦C. For use as probes for
lipids, aliquots were stored in 50% glycerol at −20◦C.
Cells
Cells (except DT-40) were grown in growth medium [DMEM
(Dulbecco’s modiﬁed Eagle’s medium) supplemented with 10%
(v/v)FBS(fetalbovineserum),100 units/mlpenicillin,100 μg/ml
streptomycin]at37◦C,inahumidiﬁed10%CO2 atmosphere,and
werepassagedtwiceperweekbygentledissociationwithTrypLE
(all from Invitrogen). DT-40 cells were cultured as described
previously in [28].
Cells (1000–2000) were plated the day before transfection
or staining in a ﬁnal volume of 25 μl on Teﬂon-coated
glass slides containing eight 6 mm wells (Scientiﬁc Laboratory
Supplies) pre-coated with poly-L-lysine. For DT-40 cells, slides
were also coated with Cell-Tak according to the manufacturer’s
instructions (BD Biosciences). For transfection, 5 μl of Opti-
MEM (Invitrogen) containing 50 ng DNA and 150 ng Lipofect-
amine
TM 2000(Invitrogen),pre-complexedfor20 min,wasadded
to the adherent cells in 25 μl growth medium. This was replaced
with 25 μl of fresh growth medium after 4 h.
Where treated with inhibitors prior to ﬁxation, the indicated
agents were applied in DMEM (without Phenol Red or sodium
pyruvate) supplemented with 25 mM Hepes, pH 7.4 (Invitrogen)
and 10% (v/v) FBS.
Plasma membrane staining
This is modiﬁcation from a previously published protocol
described in [29]. Cells in 25 μl growth medium were rapidly
ﬁxed by the addition of 25 μl aldehyde in PBS to achieve a
ﬁnal concentration of 4% FA and 0.2% GA (glutaraldehyde);
ﬁxation was allowed to proceed for 15 min at room temperature
(20–24◦C) before rinsing three times with PBS containing
50 mM NH4Cl. Slides were then placed on a metal plate in
a deep ice bath and chilled for at least 2 min. All subsequent
steps were performed on ice, with all solutions pre-chilled.
Cells were blocked and permeabilized for 45 min with a
solution of buffer A containing 5% (v/v) NGS (normal goat
serum), 50 mM NH4Cl and 0.5% saponin. 100 nM GST–
PH-PLCδ1 was included at this stage when the protein was
used as a probe for PtdIns(4,5)P2, and GST-tagged protein
wasthenremovedbytworinseswithbufferA.Primaryantibodies
were applied in buffer A with 5% NGS and 0.1% saponin for
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1 h. After two washes in buffer A, a 45 min incubation with
secondary antibody in buffer A with 5% NGS and 0.1% saponin
was performed. Slides were then rinsed four times with buffer A,
and cells were post-ﬁxed in 2% FA in PBS for 10 min on ice,
before warming to room temperature for an additional 5 min. FA
was removed by three rinses in PBS containing 50 mM NH4Cl,
followed by one rinse in distilled water. Wells were then dried,
covered with 3 μl ProLong Gold (Invitrogen) supplemented with
1 μg/ml DAPI (4
 ,6-diamidino-2-phenylindole) and covered
with22 mm×22 mmglasscoverslips(No.1thickness,Scientiﬁc
Laboratory Supplies), and sealed with nail varnish.
Golgi staining
All steps were performed at room temperature. Cells in 25 μl
medium were ﬁxed by the addition of 25 μl pre-warmed FA in
PBS to a ﬁnal concentration of 2%, and incubated for 15 min.
After removing FA with three rinses in PBS containing 50 mM
NH4Cl, cells were permeabilized for 5 min by the addition of
20 μM digitonin in buffer A for 5 min. Digitonin was removed by
three rinses in buffer A, and cells were blocked for 45 min with
buffer A supplemented with 5% (v/v) NGS and 50 mM NH4Cl.
When staining for PtdIns3P,0 . 5μg/ml GST–2×FYVE-Hrs was
included at this stage. After removing GST-tagged proteins by
two washes in buffer A, primary and secondary antibodies were
applied in buffer A with 5% NGS, before post-ﬁxation for 5 min
in 2% FA and mounting, as described above for the plasma
membrane protocol.
Lipid dyes
When staining for surface glycoproteins, 50 μg/ml Alexa Fluor®
555-conjugated WGA (wheat-germ agglutinin; Invitrogen) was
applied to the cells on ice for 5 min in DMEM (without Phenol
Red or sodium pyruvate) supplemented with 25 mM Hepes
(Invitrogen) and 10% FBS, rinsed twice in the same solution and
then ﬁxed as above. Staining for plasma membrane PtdIns(4,5)P2
or endosomal PtdIns3P were performed as described in the
precedingtwosections.Forstainingoftheendoplasmicreticulum,
afterpost-ﬁxationandrinsinginPBS/NH4Cl,cellswereincubated
for 1 min with DiOC6 (3,3
 -dihexyloxacarbocyanine iodide;
Invitrogen) in PBS, rinsed once with distilled water and mounted
in ProLong Gold with 1 μg/ml DAPI as above. A similar protocol
was used to stain cells with 500 μMD i D( 1 , 1
 -dioctadecyl-
3,3,3
 ,3
 -tetramethylindodicarbocyanine perchlorate; Invitrogen).
For Golgi staining, the slides were chilled on ice for 2 min
following the post-ﬁxation and rinsing. They were incubated
with a 5 μM solution of NBD-C6-ceramide [N-(ε-7-nitrobenz-2-
oxa-1,3-diazol-4-yl-aminocaproyl)-D-erythro-sphingosine] com-
plexed to BSA (Invitrogen) in PBS for 30 min on ice. Unbound
ceramide was removed with two rinses in ice-cold PBS, and
extra-Golgi ceramide was extracted by four washes with 3%
(w/v) defatted-BSA (Sigma–Aldrich) in PBS over 1 h at room
temperature. Finally, slides were stained for 5 min in 1 μg/ml
DAPI in PBS, rinsed once in distilled water and mounted in
Fluoromount-G (Southern Biotech). Note that we found retention
of this latter dye was poor in glycerol-based mountants, hence the
use of aqueous Fluoromount-G. Furthermore, slides stained with
NBD-C6-ceramide were imaged promptly after staining, since we
noticed progressive loss of the stain from the Golgi over a time
course of hours.
Microscopy
Images were acquired on a Leica SP5 confocal microscope
attached to a Leica DMI6000 inverted microscope stand.
Excitation and emission settings for the different ﬂuorophores
were:forAlexaFluor® 488andDiOC6,excitationwiththe488 nm
line of an Argon-ion laser and emission detected at 500–550 nm;
the same settings were used for NBD-C6-ceramide, except the
458 nmlineofthelaserwasused;forAlexaFluor®555,excitation
was with a 543 nm HeNe laser, and emission detected at 555–
620 nm; for Alexa Fluor® 647 and DiD, excitation was with a
633 nm HeNe laser and emission detected at 650–700 nm; for
DAPI, excitation was with a 405 nm diode laser and emission
detected at 415–485 nm. Each colour ﬂuorophore was scanned
sequentially, to avoid bleed-through, or else scanned in pairs that
were spectrally well separated (DAPI with Alexa Fluor® 555,
Alexa Fluor® 488 with Alexa Fluor® 647 or DiD) to avoid cross-
talk. Lack of cross-talk was conﬁrmed by imaging samples where
individual ﬂuorophore-labelled probes had been omitted.
For the high-resolution images shown in the Figures, a 63×
1.4 NA (numerical aperture) plan apochromatic oil-immersion
objective was used, and the pinhole was set to a diameter
corresponding to 1 Airy unit (optical section ∼240 nm) for true
confocal images. When acquiring z-stacks, images were scanned
at ∼120 nm intervals throughout the depth of the cells being
imaged. For lower resolution images, used for quantiﬁcation, a
20× 0.7 NA plan-apochromatic multi-immersion objective was
used, and the pinhole was opened fully to give an optical section
∼3 μm. Single scans were acquired for Golgi-stained specimens,
and z-stacks of three scans at 1.5 μm intervals were acquired for
plasma membrane-stained specimens, such that the entire depth
of the cells was captured. 8-bit images were acquired with gain
and offsets adjusted such that the entire dynamic range was used,
but with little or no pixel saturation.
Quantitative image analysis
All analysis was performed using the program ImageJ version
1.38 (http://rsb.info.nih.gov/ij/). Images were imported from the
Leica image format (.lif) using the LOCI bioformats importer
plugin(http://www.loci.wisc.edu/ome/formats.html).Automated
custom macros were written to quantify inositol lipid staining in
the images as described below.
Plasma membrane staining
Along with PtdIns4P and/or PtdIns(4,5)P2 staining, cells were
also stained with DAPI for nuclei and DiD for whole cell
ﬂuorescence. Image stacks were reduced to a single, 8-bit image
by use of the average intensity projection function. The nuclei
and DiD images were subject to a 5×5 median-pixel intensity
ﬁlter, the latter was background-subtracted, and both were
converted to binary images. The watershed algorithm (http://rsb.
info.nih.gov/ij/plugins/watershed.html) was run on the binary
nuclei image, and the resulting watershed lines were subtracted
from the binary DiD image via the image calculator command
to produce segmentation of touching cells. This resulted in a
segmented picture of cells, which was used as a mask for the
inositol lipid staining. The in-built ‘analyze particles’ function
was then used to measure the area and integrated pixel intensity
of cells that were not touching the edges of the image ﬁeld.
GFP-expressing cells
A similar procedure was used to that described above, except
the GFP signal was used to produce the mask without need for
DiD or DAPI staining (since GFP expression was sparse and
rarely produced more than two touching cells). Essentially, the
averaged stack was background subtracted and heavily median-
ﬁltered (8×8 pixels) to produce the binary mask, which was
again subjected to watershed segmentation to separate touching
cells.
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Golgi staining
In addition to PtdIns4P, cells were also stained for giantin. The
giantinstainingwassubjecttoa5×5median-pixelintensityﬁlter
and converted to a binary image by autothresholding; this was
dilatedbyasinglepixelusingthe‘dilate’command.Theresulting
binary image was used as a mask for the PtdIns4P staining image,
which was analysed using the ‘analyze particles’ command as
described above.
Thus integrated pixel intensity measurements for each cell
(or Golgi complex) in a ﬁeld was obtained. Typically, for each
experiment three randomly selected ﬁelds were imaged per
condition. In order for results to be pooled across independent
experiments, integrated pixel intensity, I, was normalized as
follows:
Normalized integrated ﬂuorescence =
(I − ¯ Ibg)
¯ Ictrl − ¯ Ibg
where Ictrl is the intensity for the control sample and Ibg
is the intensity of the background specimen in which anti-
PtdIns4P/PtdIns(4,5)P2 probes were omitted. Pooled, normalized
data were subjected to a Kruskal–Wallis test with Dunn’s
multiplecomparisonpost-testusingPrism4Software(Graphpad).
Results are presented as means+ −S.E.M. Statistically signiﬁcant
deviations from control are denoted as *P< 0.05, **P<0.01,
***P< 0.001.
Co-localization analysis
This was performed on magniﬁed images of Golgi stacks (such
as those shown in Figure 3a) using the Mander’s coefﬁcients
plugin (http://www.macbiophotonics.ca/imagej/index.htm). This
calculates the Pearson’s correlation coefﬁcient (r) between pixel
intensities in the two channels.
RESULTS AND DISCUSSION
Preservation of cellular membranes for immunocytochemistry
We have previously established conditions for staining of
plasma membrane PtdIns(4,5)P2 using a speciﬁc monoclonal
antibody [29]. Applying these conditions with a monoclonal anti-
PtdIns4P antibody yielded plasma membrane staining in HeLa
cells. The staining appeared speciﬁc, since it was abolished
by pre-incubation of the antibody with liposomes containing
5 % (mol/mol) di-palmitoyl PtdIns4P, but not with any other
inositol lipid (Figure 1). However, it was surprising to see such
an exclusive plasma membrane staining, given the extensive
evidence for a Golgi pool of PtdIns4P (described in the
Introduction section).
Preservation of plasma membrane PtdIns(4,5)P2 requires a
number of speciﬁc conditions, notably: (i) the inclusion of GA,
either alone or in conjunction with FA; (ii) the use of saponin
as the permeabilizing detergent; and (iii) maintaining tem-
peratures 4◦C during ﬁxation and staining [29]. However,
staining of Golgi membranes with the ﬂuorescent lipid NBD-
C6-ceramide was abolished by low concentrations of saponin
[30]. Therefore a comprehensive study of conditions that would
preserve various cellular membranes was undertaken. Although
there are many commercially available markers for cellular
organelles, these tend to be antibodies raised against endogenous
proteins, which will be cross-linked by aldehydes during ﬁxation
and hence become resistant to extraction by detergents. This is in
marked contrast with the lipids, which generally do not contain
primaryaminesandarethereforenotcross-linkedduringﬁxation.
Figure 1 Speciﬁcity of the anti-PtdIns4P antibody
HeLa cells were ﬁxed with 4% FA plus 0.2% GA and stained on ice using saponin
permeabilization, as described in the Experimental section. Anti-PtdIns4P antibody was
pre-absorbed with POPC liposomes containing 5% (mol/mol) of the indicated inositol lipid for
1 h at room temperature prior to applying to the cells on ice. Anti-PtdIns4P antibody staining
is yellow, and DAPI-stained nuclei are in blue. Scale bar=20μm. Images are single confocal
optical sections.
For these reasons, we chose probes that either detect endogenous
lipids, or are ﬂuorescent lipids themselves and can intercalate
into the bilayer. Such probes should provide an indication of
the integrity of the endogenous organellar membranes. COS-7
ﬁbroblasts were used for this purpose, as these cells have a large,
ﬂat cytoplasm in which visualization of various organelles is
convenient.
Figure 2 shows the results from such a study, where strength of
ﬁxation was varied (by increasing FA concentration and adding
GA), staining at room temperature was compared to staining on
ice, and the permeabilizing detergent digitonin was compared
with saponin. Using NBD-C6-ceramide as a post-ﬁxation marker
for Golgi membranes [30], it is clear that staining is abolished
by saponin, whereas it persists when digitonin is employed
(Figure 2a). Fixation and temperature conditions did not seem
to drastically affect the staining in the presence of digitonin,
althoughdistinctGolgistainingwasclearerwhenGAwasomitted
(probably because there is reduced autoﬂuorescence in the cells).
To follow the integrity of the plasma membrane under these
conditions, we used anti-PtdIns(4,5)P2 antibodies, because this
lipid is known to be enriched at the plasma membrane [31–
34]. PtdIns(4,5)P2 staining was patchy, at best, when digitonin
was used to permeabilize cells, whereas saponin gave a much
more uniform pattern (Figure 2b). Staining was more even
and consistent when performed on ice, and also after ﬁxation
with increasing concentrations of FA, with the best results
obtained after ﬁxation with a FA/GA mix (Figure 2b). Hence
the conditions that preserve plasma membrane staining are
diametrically opposed to those best for Golgi staining.
Given the different conditions required for preservation
of Golgi and plasma membranes, further membranes were
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Figure 2 Effect of ﬁxation, detergent and temperature on the retention of various organelle-speciﬁc lipid stains
Cells were ﬁxed with the indicated concentration of aldehydes, then stained at the designated temperature after permeabilization with digitonin or saponin. See the Experimental section for details.
Agentswereusedthatspeciﬁcallylabelthe(a)Golgi(NBD-ceramide),(b)plasmamembrane(anti-PtdIns(4,5)P2 antibody),(c)endosomes(anti-GSTagainstGST–2×FYVE-HrsboundtoPtdIns3P)
or (d) endoplasmic reticulum (DiOC6). DAPI-stained nuclei are shown in blue. Scale bars=20μm.
then tested under these conditions. PtdIns3P is enriched
on endosomal membranes and can be detected using a
tandem FYVE domain probe from Hrs, which labels scattered
cytosolic puncta [25]. We therefore used a GST-tagged version
as a probe for endosomal membrane integrity, using anti-
GST antibodies to detect the bound protein. Punctate stain-
ing was abolished by use of GA in the ﬁxative, or when staining
on was performed on ice (Figure 2c). Whereas limited punctate
staining was observed at room temperature in FA-ﬁxed cells
permeabilized with saponin, by far the clearest labelling was
seen with digitonin permeabilization. Under these conditions,
the labelling appeared speciﬁc, since it co-localized with an
expressed GFP–2×FYVE-Hrs probe, and staining was inhibited
by pre-treatment of cells with the PI3K (phosphoinositide 3-
kinase) inhibitor wortmannin (see Supplementary Figure S1 at
http://www.BiochemJ.org/bj/422/bj4220023add.htm).
Finally, we used the ﬂuorescent lipid DiOC6, which labels a
continuousthread-likelatticecorrespondingtotheER,asopposed
to the brightly stained snake- or sausage-like mitochondria [35].
No great disparity was seen in cells permeabilized with saponin
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or digitonin (Figure 2d), although ice-cold temperatures during
permeabilization and staining produced the best preservation
of the ER network, with optimal results observed after GA/FA
ﬁxation.
Takingalltheseresultsintoaccount,wedecidedtoproceedwith
twodistinctstainingprotocols.Theﬁrst,calledthe‘Golgistaining
protocol’,reliesonﬁxationin2%FAandashortpermeabilization
step with digitonin, with all steps performed at room temperature.
This protocol is expected to produce good preservation of Golgi
membranes, as well as other endomembranes such as those
containingPtdIns3P(Figures2a–2c),butattheexpenseofplasma
membrane integrity (Figure 2b). Note that the best results, in
terms of Golgi labelling, were obtained when a short 5 min
permeabilization step with digitonin was performed, as longer
incubations were detrimental. Similarly, we tried a number of
concentrations of digitonin, and found 20 μMt ob ei nt h eo p t i m a l
range (results not shown).
The second procedure, called the ‘plasma membrane staining
protocol’, was selected for its ability to preserve the plasma
membrane, and involved ﬁxation with a GA/FA mix, permeab-
ilizing with saponin and performing all post-ﬁxation steps on
ice (Figure 2b). Under these conditions, good preservation of
ER membranes is expected (Figure 2d), although Golgi and
endosomal membrane staining will be abolished (Figures 2a
and 2c). This procedure is a modiﬁcation of the method
previously published in [29]. First, ﬁxation in the new protocol
was performed at room temperature for 15 min, as temperature
during ﬁxation was not found to be critical for preservation
of plasma membrane staining (G.R.V. Hammond, unpublished
observations). Secondly, GA concentrations of 0.05% and
greater were sufﬁcient to produce optimal plasma membrane
labelling, although higher concentrations caused elevated levels
of autoﬂuorescence. Thirdly, considerably shorter incubation
periods (see the Experimental section) were found to be sufﬁcient
compared to the previous report, and even to produce better
results.Finally,althoughtheconcentrationofsaponin(0.1–0.5%)
is relatively high, we found staining of the plasma membrane
was less even and intense at lower concentrations. Similarly,
inclusion of saponin throughout the staining protocol was found
to be optimal and exposure of cells to shorter periods of saponin
permeabilization produced less labelling (results not shown). We
havealsotriedusingTween20asthepermeabilizingagent,asthis
was shown to produce staining of the plasma membrane and nuc-
lear envelope with anti-PtdIns(3,4)P2 antibodies [36]. However,
this did not produce such a consistent membrane labelling with
anti-PtdIns(4,5)P2 whencomparedtosaponin(resultsnotshown).
The use of cooler temperatures during staining for PtdIns
(4,5)P2 has also been shown to produce better labelling by
other groups for various probes [31,32]. Furthermore, recent
studiesusingvariousprobesforPtdIns(4,5)P2 andPtdIns(3,4,5)P3
have described ﬁxation with GA/FA, coupled with saponin
permeabilization, resulting in good retention of labelling at the
plasma membrane [37–40]. It has also been reported that calcium
should be sequestered during ﬁxation, with EGTA, to prevent
PtdIns(4,5)P2 breakdown[32],althoughwhencomparingﬁxation
using a GA/FA mix, we have seen no difference between cells
ﬁxed in the presence or absence of EGTA (G. R. V. Hammond,
unpublished observations). Together, these studies demonstrate
the general application of the above conditions for staining of
inositol lipids.
Golgi staining protocol
Staining of COS-7 cells with anti-PtdIns4P using the ‘Golgi
staining protocol’ described above produced labelling of peri-
nuclear structures resembling the Golgi apparatus (see Figures 3–
6). To formally identify this structure as the Golgi, we performed
co-localization experiments with the PH domain from FAPP1,
as this protein exhibits PtdIns4P-dependent localization to Golgi
membranes [10,22,26,41]. COS-7 cells were either transfected
with a GFP-tagged FAPP1 PH domain or were co-labelled with a
GST-conjugatedrecombinantversion.Ineithercase,goodoverlap
was seen between these probes and anti-PtdIns4P (Figure 3a).
Green ﬂuorescence of PH-FAPP1 was generally coincident with
the red staining of the antibody, but there were regions of
red ﬂuorescence devoid of PH domain labelling (Figure 3a).
This is perhaps explained by the fact that PH-FAPP1 detects
PtdIns4P only where it is co-incident with the small GTPase Arf1
[10,22].
We also performed co-localization experiments with other
markers of the Golgi apparatus, namely the cis/medial-resident
giantin and GM130 proteins, the trans-Golgi recruited clathrin
adaptor AP-1 (adaptor protein 1) and the Golgi/late endosome
cycling M6PR. All showed staining tightly juxtaposed with the
PtdIns4P antibody (Figures 3a and see Supplementary Figure S2
athttp://www.BiochemJ.org/bj/422/bj4220023add.htm).Further-
more,PtdIns4PsynthesisisimportantforER-to-Golgi trafﬁcking
from ER exit sites [42], so we co-labelled the cells with p115, a
marker of the ERGIC (ER-Golgi intermediate compartment) and
cis-Golgi membranes ([43,44]; Figure 3a), which again showed
a distribution tightly juxtaposed with PtdIns4P staining. We
quantiﬁed the overlap using Pearson’s correlation coefﬁcient (r),
a simple metric that measures the degree of correlation between
pixel intensities in the two channels, and hence degree of overlap.
This analysis was calibrated by establishing the maximum
degree of co-localization (theoretically, r=1, actually r=0.97)
by detecting the anti-PtdIns4P antibody with two different
colours of secondary antibodies (Figure 3b). The minimum
overlap (theoretically, r=0) was measured by correlating the
anti-PtdIns4P antibody staining without another marker present
(r=0.19, Figure 3b). All of the Golgi markers showed a very
similar degree of overlap with PtdIns4P, regardless of their
localization at cis-, medial- and trans-Golgi compartments, or
at the ERGIC (Figure 3b and Table 1). In addition, none
of the markers were as tightly distributed with PtdIns4P-
labelling as with the PtdIns4P-reporter PH-FAPP1 (Figure 3b
and Table 1). Together, these results conﬁrm staining of the
Golgi apparatus with the anti-PtdIns4P antibody, although it
is not possible to ascertain the sub-Golgi localization of the
signal at the resolution of the light microscope. We observed
similar staining tightly juxtaposed with giantin in a number of
different cell lines from diverse lineages, including epithelial
cells [CHO (Chinese-hamster ovary), HEK (human embryonic
kidney cells)-293, HeLa], a chicken B-cell lymphoma (DT40)
and a neuroblastoma/motor neuron fusion cell line (NSC-34), as
shown in Figure 3c.
Whereas Golgi staining is apparent using anti-PtdIns4P anti-
body, no such staining is observed with anti-PtdIns(4,5)P2
antibodyunderthesameconditions(seeSupplementaryFigureS3
at http://www.BiochemJ.org/bj/422/bj4220023add.htm), consis-
tent with the observation that PtdIns(4,5)P2 is not prevalent in the
Golgi [31]. Replacing digitonin with Triton X-100, which would
be expected to completely solubilize the Golgi membranes in
ﬁxed cells [30], abolishes Golgi staining with anti-PtdIns4P (see
Supplemental Figure S3). On the other hand, the same treatment
unmasks a speckled nuclear staining with the anti-PtdIns(4,5)P2
antibody, as has already been well-characterized with this anti-
body [45,46]. This observation underscores the importance
of selecting appropriate conditions for detection of lipids
in speciﬁc membranes (compare anti-PtdIns(4,5)P2 labelling in
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Table 1 Co-localization between anti-PtdIns4P antibody labelling and Golgi markers
Results of a Kruskal–Wallis test with Dunn’s multiple comparison test for differences between the Pearson’s correlation coefﬁcients (r) presented in Figure 3(b). Numbers in parentheses represent
number of cells for each marker (n). Anti-PtdIns4P antibody was visualized using the Alexa Fluor® 555-conjugated secondary antibody, and Pearson’s correlation coefﬁcient (r) between this and
the Alexa Fluor® 488-conjugated antibody staining of the second probe was quantiﬁed as described in the Experimental section. For anti-PtdIns4P antibody with itself, Alexa Fluor® 488 and Alexa
Fluor® 555 goat anti-mouse secondary antibodies were used to produce a ‘perfect’ co-localization. For ‘None’, an Alexa Fluor® 488-conjugated goat anti-rabbit secondary was used without primary
antibody. n.s., not signiﬁcant; *, P <0.05; **, P <0.01; ***, P <0.001.
PtdIns4P GST–PH-FAPP1 giantin p115 GM130 M6PR AP-1 AP-3
PtdIns4P (34)
GST–PH-FAPP1 (29) n.s.
giantin (110) *** **
p115 (36) *** *** n.s.
GM130 (32) *** *** n.s n.s.
M6PR (58) *** *** * n.s. n.s.
AP-1 (47) *** *** n.s n.s. n.s. n.s.
AP-3 (73) *** *** *** *** *** *** ***
None (33) *** *** *** *** *** *** *** n.s.
Figure 3 Anti-PtdIns4P antibody labels the Golgi apparatus at room temperature after 2% FA ﬁxation and digitonin permeabilization
(a) COS-7 cells were stained with anti-PtdIns4P antibody. Where indicated cells were expressing a GFP-tagged PH domain from FAPP1 (expressed for 24h) and were co-stained using either
an anti-GST antibody (against the puriﬁed GST-tagged FAPP1 PH domain) or antibodies against the indicated markers. Scale bars=5 μm. (b) Pearson’s correlation coefﬁcients for co-localized
intensity were calculated between labelling for PtdIns4P and the indicated marker, as described in the Experimental section. Images not shown in (a) are in Supplementary Figure S2 at
http://www.BiochemJ.org/bj/422/bj4220023add.htm.Results arepresented as means+ −S.E.M. and a statistical comparisonis shownin Table 1. (c) PtdIns4P and giantin labelling in a variety of cell
types. Scale bars=20μm. Images are single confocal optical sections.
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Figure 4 Co-localization of PtdIns4P and PtdIns3P with internalized EGF
COS-7 cells were serum-starved overnight, then incubated for 30min with 10 μg/ml Alexa
Fluor® 488-conjugatedEGF,priortoﬁxingandstainingforPtdIns4P andPtdIns3P asdescribed
inFigure3.Imageslabelled‘zoom’showtheenlargedregionoutlinedinthepanelsabove.Scale
bars=5 μm. Images are single confocal optical sections.
Figure 2(b) with that after Triton X-100 in Supplemental Fig-
ure S3).
Inadditiontotheperi-nuclearGolgistaining,theanti-PtdIns4P
antibody also labelled a few scattered cytosolic puncta (see
PtdIns4P channel in Figures 3–6). As several studies have
identiﬁedthepresenceoftypeIIPI4Ksinendocyticcompartments
[13–15], we undertook co-labelling experiments to test whether
anti-PtdIns4P stained these structures. Speciﬁcally, PtdIns4P has
been reported to interact directly with the clathrin adaptor AP-1
at trans-Golgi membranes [8], and PI4K IIα has been shown to
localizetolysosomal/endosomalstructurescontainingtheclathrin
adaptor AP-3 [15]. However, the anti-PtdIns4P positive puncta
were clearly distinct from the cytosolic structures labelled with
probesagainsteitheradaptor(Figure3a).Despitetheperi-nuclear
enrichment of AP-3 staining, labelling was poorly co-incident
with the Golgi PtdIns4P signal (Figure 3a) as shown by the co-
localization analysis (Figure 3b and Table 1).
Type IIα PI4K has been reported at speciﬁc endosomal
compartments containing internalized EGF receptors [14]. To
further explore the distribution of such endosomes, COS-7 cells
were loaded with ﬂuorescent EGF for 30 min, before ﬁxing and
co-staining with the anti-PtdIns4P antibody. The cells were also
stainedusinganti-GSTantibodiestodetectGST-2×FYVE-Hrs,a
probe for PtdIns3P, which is known to be prevalent in endosomes
[25]. Figure 4 shows that cytosolic PtdIns4P-labelled puncta
were excluded from the EGF-containing structures, as well as
from PtdIns3P-containing endosomes, despite the fact that the
majority of EGF puncta appeared to be within PtdIns3P-labelled
endosomes(Figure4).Therefore,thepunctatecytosolicstructures
labelled with anti-PtdIns4P do not correlate with membranes
known to contain PtdIns4P (or enzymes that synthesize it); the
speciﬁc identity and functional relevance of PtdIns4P in such
compartments is a future avenue of research.
Figure 5 Competition for Golgi PtdIns4P staining by PH-FAPP1
(a) The indicated GST-tagged fusion proteins (10μM) were included with the primary
anti-PtdIns4P antibody and anti-giantin antibodies applied to COS-7 cells. Staining
conditions are as Figure 3. Single confocal optical sections are shown. Scale bar=20μm.
(b) Quantiﬁcation of anti-PtdIns4P antibody labelling (n=207). See the Experimental section
for details. ***P <0.001.
To further assess the speciﬁcity of Golgi staining with anti-
PtdIns4P, we used GST-tagged PH-FAPP1 at high concentration
(10 μM) to sequester the endogenous PtdIns4P. This protein
indeed abolishes staining, whereas GST alone had no affect
(Figures 5a and 5b). GST–PH-PLCδ1, which should be more
speciﬁc for PtdIns(4,5)P2 compared with PtdIns4P [47,48]
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did not abolish Golgi staining (Figure 5a), but quantitative
analysis revealed an approx. 50% decrease in staining intensity
(Figure 5b). This might suggest that some of the observed
signal with the anti-PtdIns4P antibody is due to the presence
of PtdIns(4,5)P2, as PH-FAPP1 can bind both lipids in vitro [23].
This,however,seemsunlikelygiventhespeciﬁcityoftheantibody
for exogenous competing lipid (Figure 1), as well as the fact that
anti-PtdIns(4,5)P2 does not label the Golgi (see Supplemental
Figure S3), which is known to anyway contain relatively little
PtdIns(4,5)P2 [31]. Rather, we suspect the partial competition is
due to some weak PtdIns4P-binding by PH-PLCδ1, which may
be exacerbated by the high concentration of protein used, and the
presence of the GST tag, which effectively increases afﬁnity [49].
PtdIns4P is synthesized by at least two Golgi-resident PI4Ks,
PI4K IIα and PI4K IIIβ [1,41], although the evidence suggests
that PI4K IIβ may also play a role [50]. To address the relative
contributions of these isoforms to Golgi PtdIns4P staining,
we incubated cells for 30 min before ﬁxation with a high
concentration of wortmannin (10 μM), which should abolish
type IIIβ (and α) activity [11]. Figure 6 shows that wortmannin
addition produces no detectable change in the PtdIns4P staining
intensity at the Golgi, despite the fact that it induces partial
dissociation of PtdIns4P-bound proteins [26] and a redistribution
of Golgi PtdIns4P [41] over this time period. This result suggests
that the type III enzyme contributes a relatively small, or slowly
turned-over fraction, of the steady-state PtdIns4P levels in the
Golgi, despite the functional importance of this enzyme to
Golgi function [11,51]. It can also be inferred that a type II
activity generates the majority of the steady-state pool. However,
unambiguous assignment of PI4K activities to distinct pools of
PtdIns4P are hampered by a lack of pharmacological inhibitors
of the type II enzymes, and RNA-interference based methods
have been shown to produce only very minor effects on cellular
PtdIns4P levels [20].
We also tested the arsenical compound PAO (phenylarsine
oxide)(Figure6).Surprisingly,10 μMPAOdramaticallyreduced
Golgi PtdIns4P staining (Figure 6b), resulting in scattered
cytosolic puncta (Figure 6a). PAO reacts with sulfhydryl groups,
and its effects are reversed by a powerful reducing agent such
as DTT (dithiothreitol), but not by the weaker 2-mercaptoethanol
(Figure 6b), consistent with earlier reports [20]. PAO primarily
inhibits PI4K IIIα at this concentration, which should also be
blocked by 10 μM wortmannin [13]. Therefore, this result is not
a direct effect of PAO on Golgi PI4Ks.
In parallel experiments, we measured the effects of these
compounds on staining using the anti-GST antibodies to
detect GST–2×FYVE-Hrs-bound endosomal PtdIns3P (see
SupplementalFigureS1).WhereasPAOhadnoeffectonstaining,
wortmannin caused a dramatic diminution of staining at 300 nM,
a concentration selective for PI3K over PI4K.
Plasma membrane staining
Consistent with the observations from Figure 1, staining of cells
using the ‘plasma membrane staining’ protocol generates surface
labelling of cells with anti-PtdIns4P antibody. This can be seen in
COS-7 cells co-stained with Alexa® Fluor 555-conjugated WGA
to label surface glycoproteins (Figures 7a and 7b). Owing to the
ﬂattened nature of adherent COS-7 cells, the plasma membrane
does not appear as a ring of ﬂuorescence in confocal optical
sections, although sections through the z-axis reveal the surface
nature of the labelling (Figure 7a). A clearer example of this
surface labelling is seen in COS-7 cells adhered to glass for
just 20 min prior to ﬁxation, (i.e. before they have had time to
spread).Thesecellsclearlyshowaringofsurfacelabellinginboth
Figure 6 Effect of PI4K inhibitors on Golgi PtdIns4P labelling
(a) COS-7 cells were pre-treated for 30min at 37◦C with 0.1% DMSO (Ctrl), 10 μMP A O
with 1mM 2-mercaptoethanol or DTT (PAO+β-mer or PAO+DTT) and 300nM or 10μM
wortmannin (Wmn) as indicated, prior to ﬁxation and staining as described in Figure 3. Single
confocal optical sections are shown. Scale bar=20μm. (b) Quantiﬁcation of anti-PtdIns4P
labelling (n=237). See Experimental section for details. *** P <0.001.
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Figure7 Anti-PtdIns4P antibodylabelstheplasmamembraneofcellsﬁxed
with FA and GA, permeabilized with saponin and stained on ice
(a) COS-7 cells grown overnight prior to ﬁxation and staining or (b) ﬁxed and stained 20min
afterseedingonpoly-L-lysine.Inbothcases,cellswereincubatedfor5 minonicewith50μg/ml
Alexa Fluor® 555-conjugated WGA prior to ﬁxing to label the plasma membrane. (c) Different
cell types stained with anti-PtdIns4P antibody using the above conditions. All images show
single confocal optical sections in the xy plane (upper panels), or sections through the z plane
(lower panels). Scale bars=20μm.
x-, y-a n dz-confocal sections (Figure 7b). As for Golgi staining,
this surface labelling was also observed in a number of other
cell types (Figure 7c). Note that in subsequent experiments, to
clearly show changes in whole-cell plasma membrane labelling,
maximum intensity projections from confocal sections spanning
the entire depth of the cells are shown. Hence the staining appears
rather uniform across the cells.
The speciﬁcity of the staining was again assessed by
sequestration of endogenous PtdIns4P with GST–PH-FAPP1.
As seen for Golgi staining, this completely abolished staining,
whereas GST alone had no effect (Figure 8). However, the
PtdIns(4,5)P2-sequestering PH domain from PLCδ1 produced a
nearablationofstaining(Figure8).Thisisinmarkedcontrastwith
parallel experiments using anti-PtdIns(4,5)P2 antibody, where
onlyGST–PH-PLCδ1wasabletoabolishstaining,consistentwith
ourearlierreport[29].GiventhespeciﬁccompetitionofPtdIns4P
staining by exogenous PtdIns4P compared with PtdIns(4,5)P2
(Figure 1), it seems unlikely that this result reﬂects reactivity of
anti-PtdIns4P antibody with plasma membrane PtdIns(4,5)P2.A s
arguedabove,itmaysimplyreﬂectbindingofhighconcentrations
of GST–PH-PLCδ1 to plasma membrane PtdIns4P.H o w e v e r ,
given the enrichment of PtdIns(4,5)P2 at the plasma membrane,
cross-reactivity was more of a concern than for Golgi staining, so
we conceived further experiments to eliminate this possibility.
Figure 8 Competition for plasma membrane PtdIns4P staining by PH-
FAPP1
(a) The indicated GST-tagged fusion proteins were included at 10μM with the primary
anti-PtdIns4P or anti-PtdIns(4,5)P2 antibodies applied to COS-7 cells. Staining conditions
are as in Figure 7. Images are maximum intensity projections of confocal sections spanning
the entire depth of the cells. Scale bar=20μm. DAPI stained nuclei are in blue indicating the
presence of cells where lipid staining is absent. (b) Quantiﬁcation of staining (n=126 cells for
anti-PtdIns4P antibody and 123 cells for anti-PtdIns(4,5)P2 antibody). See the Experimental
section for details. ***P <0.001.
Expression of an inositol 5-phosphatase activity would be
expectedtodecreasePtdIns(4,5)P2 levelsintheplasmamembrane
without depletion of PtdIns4P. To this end, we transfected COS-7
cells with GFP-tagged pharbin, an enzyme with PtdIns(4,5)P2
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Figure 9 Effect of a 5-phosphatase on plasma membrane PtdIns4P/
PtdIns(4,5)P2 labelling
COS-7cellsweretransfectedwithGFP,GFP-Pharbinortheputativelyinactivemutantofthelatter,
D559A,for18hpriortoﬁxationandstainingasdescribedinFigure7.(a)Representativeimages
of COS-7 cells transfected with each construct. Images are maximum intensity projections of
confocal sections spanning the entire depth of the cells. Scale bar=20μm. (b) Quantiﬁcation
of staining (n=93 cells). See the Experimental section for details. *P <0.05, **P <0.01.
5-phosphatase activity [52]. Cells were then ﬁxed and co-
stained with an anti-PtdIns4P antibody and anti-GST antibody to
stain for GST–PH-PLCδ1 and follow PtdIns(4,5)P2 [31]. Over-
expressed pharbin was localized throughout the cytosol and
was particularly enriched on the Golgi, as reported previously
in [52,53]. Despite its preference for PtdIns(3,4,5)P3 as a
substrate [53], the over-expressed enzyme caused reduction in
the intensity of staining against PtdIns(4,5)P2 compared with
neighbouring cells without visible GFP expression. This effect
was not seen in GFP-expressing cells or in cells expressing a
mutant pharbin, with the putative catalytic aspartate-559 residue
mutated to alanine (Figure 9a). Quantiﬁcation of ﬂuorescence
images showed that pharbin caused an approx. 50% decrease in
staining for PtdIns(4,5)P2 (Figure 9b). Importantly, no reduction
in staining for PtdIns4P was detected (Figure 9b), and in fact the
quantiﬁcationrevealedaslightincreaseinPtdIns4Pstaining.This
isprobablynotduetocatalyticproductionofPtdIns4Pbypharbin
as it is also seen with the inactive mutant (Figure 9b).
Together, these experiments provide evidence for the existence
of a substantial pool of plasma membrane PtdIns4P,a sh a s
Figure 10 Effect of PI4K inhibitors on plasma membrane PtdIns4P and
PtdIns(4,5)P2 labelling
(a) COS-7 cells were pre-treated for 30min at 37◦C with 0.1% DMSO (Ctrl), 10 μMP A O
with 1mM 2-mercaptoethanol or DTT (PAO+β-mer or PAO+DTT), 300nM or 10μM
wortmannin (Wmn) as indicated, prior to ﬁxation and staining with anti-PtdIns4P antibody
and GST–PH-PLCδ1 as described in Figure 7. Images are maximum intensity projections of
confocal sections spanning the entire depth of the cells. Scale bar=20μm. (b) Quantiﬁcation
of staining (n=136 cells). See the Experimental section for details. ***P <0.001.
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been reported in cells expressing GFP-fusions of the PtdIns4P-
binding PH domain from Osh2p [20,23]. It has been shown that
the plasma membrane pool of PtdIns(4,5)P2 required for PLC
signalling is synthesized via PI4K IIIα [20,26,54]. PI4K IIIα is
uniquely sensitive to wortmannin and 10 μM PAO [13], so we
pre-incubated cells with these drugs for 30 min prior to ﬁxation
and staining for plasma membrane PtdIns4P and PtdIns(4,5)P2.
WortmanninabolishesplasmamembranePtdIns4Pstainingatthe
high (10 μM), but not lower (300 nM), concentrations speciﬁc
for PI3K (Figure 10). PAO also abolishes plasma membrane
PtdIns4P staining (Figure 10), and this is reversed by DTT
and not by 2-mercaptoethanol, as reported previously [20].
Surprisingly, plasma membrane staining for PtdIns(4,5)P2 was
completely unaffected by treatment with either drug (Figure 10).
A similar observation has been made after metabolic labelling
of inositol lipids with 2-[
3H]-inositol or [
32P]-phosphate [20,55],
andsuggeststhatthesteady-stateplasmamembranePtdIns(4,5)P2
is turning-over much more slowly than the PtdIns4P pool, or
else is synthesized from PtdIns4P made by an entirely different
PI4K activity. Either way, this observation indicates that despite
beingtheprecursorforPtdIns(4,5)P2 synthesis,plasmamembrane
PtdIns4P pools are metabolically distinct from the steady-state
PtdIns(4,5)P2 pool.
Previous reports using anti-PtdIns4P antibodies have not
generated evidence for plasma membrane PtdIns4P [8,56],
although the conditions used for staining in those experiments
were not particularly amenable for the preservation of the plasma
membrane (Figure 2). In the present study, there is unambiguous
evidence for distinct pools of PtdIns4P in Golgi and plasma
membranes. What is the relative abundance of these two pools?
Pre-treatment of cells with 10 μM wortmannin causes an approx.
80% drop in total cellular PtdIns4P levels, as measured by
metabolic labelling with
32P [20,54,55], and complete ablation
of plasma membrane PtdIns4P (Figure 10). Conversely, selective
depletion of Golgi PtdIns4P with a Golgi-localized Sac1 mutant
causes a reduction in radiolabelled PtdIns4P levels of approx.
20% [56]. Therefore, it appears that the major pool of PtdIns4P
turning over in resting cells is present in the plasma membrane.
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Immunocytochemical techniques reveal multiple, distinct cellular pools
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Figure S1 PtdIns3P staining with GST–2×FYVE-Hrs
(a) COS-7 cells expressing GFP-tagged 2xFYVE-Hrs were ﬁxed and were co-stained using an anti-GST antibody against GST–2×FYVE-Hrs as described in Figure 3. (b) Cells were pre-treated
with the indicated inhibitor as described in Figure 6. Scale bars=20μm. (c) Quantiﬁcation of results shown in (b)( n=30cells). See the Experimental section for details. *P <0.05,
***P <0.001.
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Figure S2 Anti-PtdIns4P antibody co-labelling with Golgi markers
COS-7 cells were ﬁxed and stained with the indicated antibodies as described in Figure 3(a).
Figure S3 Effect of detergent on PtdIns4P/PtdIns(4,5)P2 staining after FA
ﬁxation and room temperature staining
COS-7 cells were ﬁxed and processed as in Figure 3, except cells were permeabilised with
either 20 μM digitonin or 0.2% Triton X-100 as indicated, then stained with anti-PtdIns4P or
anti-PtdIns(4,5)P2 antibodies. DAPI stained nuclei are outlined. Scale bar=20 μm.
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